Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Baricitinib

Various toxicities

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Watanabe A, et al. Real-world effectiveness and safety of baricitinib including its effect on biomarkers and laboratory data in Japanese adult patients with atopic dermatitis: a single-center retrospective study. Journal of Cutaneous Immunology and Allergy 7: Jan 2024. Available from: URL: https://dx.doi.org/10.3389/jcia.2024.12455 Watanabe A, et al. Real-world effectiveness and safety of baricitinib including its effect on biomarkers and laboratory data in Japanese adult patients with atopic dermatitis: a single-center retrospective study. Journal of Cutaneous Immunology and Allergy 7: Jan 2024. Available from: URL: https://dx.doi.org/10.3389/jcia.2024.12455
Metadaten
Titel
Baricitinib
Various toxicities
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56722-5

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Triamcinolone

Case report

Pembrolizumab

Case report

Sirolimus